Correct our recent quarterly report said we have less than 3 quarters of funding left at our current cash burn. As TT has pointed out we are likely due an R and D rebate which should give us until the end of January before the company has to tell the ASX where future funds are coming from.
Many on this forum seem to feel that some kind of deal can be negotiated in that time hopefully it's beneficial to SH and doesn't just keep them in a job for a bit longer.
Ann: Douglas Cubbin appointed as Incoming Chairman of OncoSil, page-33
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.58M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $102 | 20.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 50 | 27827650 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 29345097 | 22 |
View Market Depth
| Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
0.000 ( 11.1 %) |
||||
| Open | High | Low | Volume | ||
| 0.4¢ | 0.5¢ | 0.4¢ | 129546 | ||
| Last updated 11.53am 17/05/2024 ? | |||||
| OSL (ASX) Chart |